424 related articles for article (PubMed ID: 20647322)
61. Expression of the target antigen for cytotoxic T lymphocytes on adult T-cell-leukemia cells.
Kannagi M; Matsushita S; Harada S
Int J Cancer; 1993 Jun; 54(4):582-8. PubMed ID: 8514449
[TBL] [Abstract][Full Text] [Related]
62. Conserved CDR3 regions in T-cell receptor (TCR) CD8(+) T cells that recognize the Tax11-19/HLA-A*0201 complex in a subject infected with human T-cell leukemia virus type 1: relationship of T-cell fine specificity and major histocompatibility complex/peptide/TCR crystal structure.
Bourcier KD; Lim DG; Ding YH; Smith KJ; Wucherpfennig K; Hafler DA
J Virol; 2001 Oct; 75(20):9836-43. PubMed ID: 11559817
[TBL] [Abstract][Full Text] [Related]
63. Immunologic control of human T-cell leukemia virus type I and adult T-cell leukemia.
Kannagi M
Int J Hematol; 2007 Aug; 86(2):113-7. PubMed ID: 17875523
[TBL] [Abstract][Full Text] [Related]
64. Cytotoxic T lymphocyte lysis of HTLV-1 infected cells is limited by weak HBZ protein expression, but non-specifically enhanced on induction of Tax expression.
Rowan AG; Suemori K; Fujiwara H; Yasukawa M; Tanaka Y; Taylor GP; Bangham CR
Retrovirology; 2014 Dec; 11():116. PubMed ID: 25499803
[TBL] [Abstract][Full Text] [Related]
65. A retrospective analysis of treatment outcomes in adult T cell leukemia/lymphoma patients with aggressive disease treated with or without allogeneic stem cell transplantation: A single-center experience.
Kawada H; Yoshimitsu M; Nakamura D; Arai A; Hayashida M; Kamada Y; Maekawa K; Fujino S; Arima M; Arima N; Tabuchi T; Inoue H; Hamda H; Suzuki S; Matsushita K; Arima N
Biol Blood Marrow Transplant; 2015 Apr; 21(4):696-700. PubMed ID: 25542158
[TBL] [Abstract][Full Text] [Related]
66. [New treatment strategy for adult T-cell leukemia targeting for anti-tumor immunity and a longevity gene-encoded protein].
Kozako T
Yakugaku Zasshi; 2011; 131(7):1061-72. PubMed ID: 21720136
[TBL] [Abstract][Full Text] [Related]
67. Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells.
Kannagi M; Shida H; Igarashi H; Kuruma K; Murai H; Aono Y; Maruyama I; Osame M; Hattori T; Inoko H
J Virol; 1992 May; 66(5):2928-33. PubMed ID: 1373197
[TBL] [Abstract][Full Text] [Related]
68. Tumor immunity against adult T-cell leukemia.
Kannagi M; Harashima N; Kurihara K; Ohashi T; Utsunomiya A; Tanosaki R; Masuda M; Tomonaga M; Okamura J
Cancer Sci; 2005 May; 96(5):249-55. PubMed ID: 15904464
[TBL] [Abstract][Full Text] [Related]
69. [Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma].
Utsunomiya A
Rinsho Ketsueki; 2016; 57(10):2190-2198. PubMed ID: 27795530
[TBL] [Abstract][Full Text] [Related]
70. Cytotoxic T cell response and expression of the target antigen in HTLV-I infection.
Kannagi M; Matsushita S; Shida H; Harada S
Leukemia; 1994 Apr; 8 Suppl 1():S54-9. PubMed ID: 8152305
[TBL] [Abstract][Full Text] [Related]
71. Tax is a potential molecular target for immunotherapy of adult T-cell leukemia/lymphoma.
Suzuki S; Masaki A; Ishida T; Ito A; Mori F; Sato F; Narita T; Ri M; Kusumoto S; Komatsu H; Fukumori Y; Nishikawa H; Tanaka Y; Niimi A; Inagaki H; Iida S; Ueda R
Cancer Sci; 2012 Oct; 103(10):1764-73. PubMed ID: 22735080
[TBL] [Abstract][Full Text] [Related]
72. Clinical significance of CD70 expression on T cells in human T-lymphotropic virus type-1 carriers and adult T cell leukemia/ lymphoma patients.
Masamoto I; Yoshimitsu M; Kuroki A; Horai S; Ezinne CC; Kozako T; Hachiman M; Kamada Y; Baba M; Arima N
Leuk Lymphoma; 2016; 57(3):685-91. PubMed ID: 26077361
[TBL] [Abstract][Full Text] [Related]
73. Reduced Tim-3 expression on human T-lymphotropic virus type I (HTLV-I) Tax-specific cytotoxic T lymphocytes in HTLV-I infection.
Abdelbary NH; Abdullah HM; Matsuzaki T; Hayashi D; Tanaka Y; Takashima H; Izumo S; Kubota R
J Infect Dis; 2011 Apr; 203(7):948-59. PubMed ID: 21402546
[TBL] [Abstract][Full Text] [Related]
74. Repression of tax expression is associated both with resistance of human T-cell leukemia virus type 1-infected T cells to killing by tax-specific cytotoxic T lymphocytes and with impaired tumorigenicity in a rat model.
Nomura M; Ohashi T; Nishikawa K; Nishitsuji H; Kurihara K; Hasegawa A; Furuta RA; Fujisawa J; Tanaka Y; Hanabuchi S; Harashima N; Masuda T; Kannagi M
J Virol; 2004 Apr; 78(8):3827-36. PubMed ID: 15047798
[TBL] [Abstract][Full Text] [Related]
75. Correlation of major histocompatibility complex class I downregulation with resistance of human T-cell leukemia virus type 1-infected T cells to cytotoxic T-lymphocyte killing in a rat model.
Ohashi T; Hanabuchi S; Suzuki R; Kato H; Masuda T; Kannagi M
J Virol; 2002 Jul; 76(14):7010-9. PubMed ID: 12072501
[TBL] [Abstract][Full Text] [Related]
76. An altered peptide ligand antagonizes antigen-specific T cells of patients with human T lymphotropic virus type I-associated neurological disease.
Kubota R; Soldan SS; Martin R; Jacobson S
J Immunol; 2000 May; 164(10):5192-8. PubMed ID: 10799878
[TBL] [Abstract][Full Text] [Related]
77. Molecular Pathology of Adult T-Cell Leukemia/Lymphoma.
Ohshima K
Oncology; 2015; 89 Suppl 1():7-15. PubMed ID: 26550829
[TBL] [Abstract][Full Text] [Related]
78. In vivo dynamics and adaptation of HTLV-1-infected clones under different clinical conditions.
Izaki M; Yasunaga JI; Nosaka K; Sugata K; Utsunomiya H; Suehiro Y; Shichijo T; Yamada A; Sugawara Y; Hibi T; Inomata Y; Akari H; Melamed A; Bangham C; Matsuoka M
PLoS Pathog; 2021 Feb; 17(2):e1009271. PubMed ID: 33524072
[TBL] [Abstract][Full Text] [Related]
79. HTLV-1 Tax-specific memory cytotoxic T lymphocytes in long-term survivors of aggressive-type adult T-cell leukemia/lymphoma.
Jo T; Noguchi K; Sakai T; Kubota-Koketsu R; Irie S; Matsuo M; Taguchi J; Abe K; Shigematsu K
Cancer Med; 2022 Sep; 11(17):3238-3250. PubMed ID: 35315593
[TBL] [Abstract][Full Text] [Related]
80. HTLV-1 Tax-Specific CTL Epitope-Pulsed Dendritic Cell Therapy Reduces Proviral Load in Infected Rats with Immune Tolerance against Tax.
Ando S; Hasegawa A; Murakami Y; Zeng N; Takatsuka N; Maeda Y; Masuda T; Suehiro Y; Kannagi M
J Immunol; 2017 Feb; 198(3):1210-1219. PubMed ID: 28011931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
